Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Developmental and Behavioral Pediatrics : JDBP|February 28, 2017
Access to Developmental Pediatrics Evaluations for At-Risk ChildrenManuel E Jimenez, Emmanuel Martinez Alcaraz, Jerome Williams, et al.
CMAJ Open|July 12, 2022
Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trialJerome Williams, Marc-Alexandre Gingras, Robert Dubé, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Evaluation of the effects of everolimus-eluting and paclitaxel-eluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trialRobert Applegate, James Hermiller, Jerome Williams, et al.
The American Journal of Cardiology|January 7, 2016
One-Year Outcomes in "Real-World" Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study [PE-Plus PAS])David E Kandzari, Nima Amjadi, Christopher Caputo, et al.
Translational Psychiatry|June 21, 2024
Development of a differential treatment selection model for depression on consolidated and transformed clinical trial datasetsKelly Perlman, Joseph Mehltretter, David Benrimoh, et al.
The American Journal of Cardiology|March 31, 2019
Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study)David E Kandzari, Nima Amjadi, Christopher Caputo, et al.
JAMA|April 24, 2008
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialGregg W Stone, Mark Midei, William Newman, et al.
Circulation|January 28, 2009
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trialGregg W Stone, Mark Midei, William Newman, et al.
Lancet (London, England)|September 30, 2018
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trialGregg W Stone, Stephen G Ellis, Tommaso Gori, et al.
Pageof 1